Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr;40(4):463-481.
doi: 10.1016/j.tibtech.2021.08.006. Epub 2021 Sep 14.

Progress and challenges in mass spectrometry-based analysis of antibody repertoires

Affiliations
Free article
Review

Progress and challenges in mass spectrometry-based analysis of antibody repertoires

Igor Snapkov et al. Trends Biotechnol. 2022 Apr.
Free article

Abstract

Humoral immunity is divided into the cellular B cell and protein-level antibody responses. High-throughput sequencing has advanced our understanding of both these fundamental aspects of B cell immunology as well as aspects pertaining to vaccine and therapeutics biotechnology. Although the protein-level serum and mucosal antibody repertoire make major contributions to humoral protection, the sequence composition and dynamics of antibody repertoires remain underexplored. This limits insight into important immunological and biotechnological parameters such as the number of antigen-specific antibodies, which are for example, relevant for pathogen neutralization, microbiota regulation, severity of autoimmunity, and therapeutic efficacy. High-resolution mass spectrometry (MS) has allowed initial insights into the antibody repertoire. We outline current challenges in MS-based sequence analysis of antibody repertoires and propose strategies for their resolution.

Keywords: B cell receptor; antibody repertoire; bioinformatics; high-throughput sequencing; immunoglobulin; mass spectrometry; proteomics.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests V.G. declares advisory board positions in aiNET GmbH and Enpicom BV. V.G. is a consultant for Roche/Genentech. The remaining authors have no interests to declare.

Publication types

LinkOut - more resources